Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-07-27 00:00:00 ET · period of report 2022-07-25 · accession 0001562180-22-005761 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-27 | 2022-07-25 | SNDX | Metzger Michael A | CEO, Dir | S - Sale+OE | $21.06 | -31.6K | 17.7K | -64% | -$665.5K |
| DM | 2022-07-27 | 2022-07-25 | SNDX | Metzger Michael A | CEO, Dir | M - OptEx | $6.38 | +31.6K | 29.5K | New | +$201.6K |
| DM | 2022-07-27 | 2022-07-25 | SNDX | Metzger Michael A | CEO, Dir | M - OptEx | $0.00 | -31.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-25 | S | D | 11,838 | $21.06 | 17,659 | D | — | — | (F2) The sale prices ranged from $21.00 to $21.16. |
| 2 | Common | Common Stock | 2022-07-25 | S | D | 19,764 | $21.06 | 17,659 | D | — | — | (F2) The sale prices ranged from $21.00 to $21.16. |
| 3 | Common | Common Stock | 2022-07-25 | M | A | 19,764 | $6.38 | 37,423 | D | — | — | |
| 4 | Common | Common Stock | 2022-07-25 | M | A | 11,838 | $6.38 | 29,497 | D | — | — | |
| 5 | Derivative | Stock Options (Right to buy) | 2022-07-25 | M | D | 11,838 | $0.00 | 0 | D | $6.38 · — to 2029-02-06 | 11,838 Common Stock | (F4) This option vests periodically upon the Issuer achieving certain milestones. |
| 6 | Derivative | Stock Options (Right to buy) | 2022-07-25 | M | D | 19,764 | $0.00 | 0 | D | $6.38 · — to 2029-02-06 | 19,764 Common Stock | (F3) This option vests in 48 successive equal monthly installments measured from 02/06/2019. |